Adult height in patients with advanced CKD requiring renal replacement therapy during childhood

Jérôme Harambat, Marjolein Bonthuis, Karlijn J. van Stralen, Gema Ariceta, Nina Battelino, Anna Bjerre, Timo Jahnukainen, Valérie Leroy, G. Reusz, Ana R. Sandes, Manish D. Sinha, Jaap W. Groothoff, Christian Combe, Kitty J. Jager, Enrico Verrina, Franz Schaefer

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Background and objectives Growth and final height are of major concern in children with ESRD. This study sought to describe the distribution of adult height of patients who started renal replacement therapy (RRT) during childhood and to identify determinants of final height in a large cohort of RRT children. Design, setting, participants, & measurements A total of 1612 patients from 20 European countries who started RRT before 19 years of age and reached final height between 1990 and 2011 were included. Linear regression analyses were performed to calculate adjusted mean final height SD score (SDS) and to investigate its potential determinants. Results The median final height SDS was -1.65 (median of 168 cm in boys and 155 cm in girls). Fifty-five percent of patients attained an adult height within the normal range. Adjusted for age at start of RRT and primary renal diseases, final height increased significantly over time from -2.06 SDS in children who reached adulthood in 1990-1995 to -1.33 SDS among those reaching adulthood in 2006-2011. Older age at start of RRT, more recent period of start of RRT, cumulative percentage time on a functioning graft, and greater height SDS at initiation of RRT were independently associated with a higher final height SDS. Patients with congenital anomalies of the kidney and urinary tract and metabolic disorders had a lower final height than those with other primary renal diseases. Conclusions Although final height remains suboptimal in children with ESRD, it has consistently improved over time.

Original languageEnglish
Pages (from-to)92-99
Number of pages8
JournalClinical Journal of the American Society of Nephrology
Volume9
Issue number1
DOIs
Publication statusPublished - Jan 7 2014

Fingerprint

Renal Replacement Therapy
Chronic Kidney Failure
Kidney
Linear Models
Reference Values
Regression Analysis
Transplants
Growth

ASJC Scopus subject areas

  • Nephrology
  • Transplantation
  • Epidemiology
  • Critical Care and Intensive Care Medicine

Cite this

Harambat, J., Bonthuis, M., van Stralen, K. J., Ariceta, G., Battelino, N., Bjerre, A., ... Schaefer, F. (2014). Adult height in patients with advanced CKD requiring renal replacement therapy during childhood. Clinical Journal of the American Society of Nephrology, 9(1), 92-99. https://doi.org/10.2215/CJN.00890113

Adult height in patients with advanced CKD requiring renal replacement therapy during childhood. / Harambat, Jérôme; Bonthuis, Marjolein; van Stralen, Karlijn J.; Ariceta, Gema; Battelino, Nina; Bjerre, Anna; Jahnukainen, Timo; Leroy, Valérie; Reusz, G.; Sandes, Ana R.; Sinha, Manish D.; Groothoff, Jaap W.; Combe, Christian; Jager, Kitty J.; Verrina, Enrico; Schaefer, Franz.

In: Clinical Journal of the American Society of Nephrology, Vol. 9, No. 1, 07.01.2014, p. 92-99.

Research output: Contribution to journalArticle

Harambat, J, Bonthuis, M, van Stralen, KJ, Ariceta, G, Battelino, N, Bjerre, A, Jahnukainen, T, Leroy, V, Reusz, G, Sandes, AR, Sinha, MD, Groothoff, JW, Combe, C, Jager, KJ, Verrina, E & Schaefer, F 2014, 'Adult height in patients with advanced CKD requiring renal replacement therapy during childhood', Clinical Journal of the American Society of Nephrology, vol. 9, no. 1, pp. 92-99. https://doi.org/10.2215/CJN.00890113
Harambat, Jérôme ; Bonthuis, Marjolein ; van Stralen, Karlijn J. ; Ariceta, Gema ; Battelino, Nina ; Bjerre, Anna ; Jahnukainen, Timo ; Leroy, Valérie ; Reusz, G. ; Sandes, Ana R. ; Sinha, Manish D. ; Groothoff, Jaap W. ; Combe, Christian ; Jager, Kitty J. ; Verrina, Enrico ; Schaefer, Franz. / Adult height in patients with advanced CKD requiring renal replacement therapy during childhood. In: Clinical Journal of the American Society of Nephrology. 2014 ; Vol. 9, No. 1. pp. 92-99.
@article{afefe30575294940ab2872379b6de78d,
title = "Adult height in patients with advanced CKD requiring renal replacement therapy during childhood",
abstract = "Background and objectives Growth and final height are of major concern in children with ESRD. This study sought to describe the distribution of adult height of patients who started renal replacement therapy (RRT) during childhood and to identify determinants of final height in a large cohort of RRT children. Design, setting, participants, & measurements A total of 1612 patients from 20 European countries who started RRT before 19 years of age and reached final height between 1990 and 2011 were included. Linear regression analyses were performed to calculate adjusted mean final height SD score (SDS) and to investigate its potential determinants. Results The median final height SDS was -1.65 (median of 168 cm in boys and 155 cm in girls). Fifty-five percent of patients attained an adult height within the normal range. Adjusted for age at start of RRT and primary renal diseases, final height increased significantly over time from -2.06 SDS in children who reached adulthood in 1990-1995 to -1.33 SDS among those reaching adulthood in 2006-2011. Older age at start of RRT, more recent period of start of RRT, cumulative percentage time on a functioning graft, and greater height SDS at initiation of RRT were independently associated with a higher final height SDS. Patients with congenital anomalies of the kidney and urinary tract and metabolic disorders had a lower final height than those with other primary renal diseases. Conclusions Although final height remains suboptimal in children with ESRD, it has consistently improved over time.",
author = "J{\'e}r{\^o}me Harambat and Marjolein Bonthuis and {van Stralen}, {Karlijn J.} and Gema Ariceta and Nina Battelino and Anna Bjerre and Timo Jahnukainen and Val{\'e}rie Leroy and G. Reusz and Sandes, {Ana R.} and Sinha, {Manish D.} and Groothoff, {Jaap W.} and Christian Combe and Jager, {Kitty J.} and Enrico Verrina and Franz Schaefer",
year = "2014",
month = "1",
day = "7",
doi = "10.2215/CJN.00890113",
language = "English",
volume = "9",
pages = "92--99",
journal = "Clinical journal of the American Society of Nephrology : CJASN",
issn = "1555-9041",
publisher = "American Society of Nephrology",
number = "1",

}

TY - JOUR

T1 - Adult height in patients with advanced CKD requiring renal replacement therapy during childhood

AU - Harambat, Jérôme

AU - Bonthuis, Marjolein

AU - van Stralen, Karlijn J.

AU - Ariceta, Gema

AU - Battelino, Nina

AU - Bjerre, Anna

AU - Jahnukainen, Timo

AU - Leroy, Valérie

AU - Reusz, G.

AU - Sandes, Ana R.

AU - Sinha, Manish D.

AU - Groothoff, Jaap W.

AU - Combe, Christian

AU - Jager, Kitty J.

AU - Verrina, Enrico

AU - Schaefer, Franz

PY - 2014/1/7

Y1 - 2014/1/7

N2 - Background and objectives Growth and final height are of major concern in children with ESRD. This study sought to describe the distribution of adult height of patients who started renal replacement therapy (RRT) during childhood and to identify determinants of final height in a large cohort of RRT children. Design, setting, participants, & measurements A total of 1612 patients from 20 European countries who started RRT before 19 years of age and reached final height between 1990 and 2011 were included. Linear regression analyses were performed to calculate adjusted mean final height SD score (SDS) and to investigate its potential determinants. Results The median final height SDS was -1.65 (median of 168 cm in boys and 155 cm in girls). Fifty-five percent of patients attained an adult height within the normal range. Adjusted for age at start of RRT and primary renal diseases, final height increased significantly over time from -2.06 SDS in children who reached adulthood in 1990-1995 to -1.33 SDS among those reaching adulthood in 2006-2011. Older age at start of RRT, more recent period of start of RRT, cumulative percentage time on a functioning graft, and greater height SDS at initiation of RRT were independently associated with a higher final height SDS. Patients with congenital anomalies of the kidney and urinary tract and metabolic disorders had a lower final height than those with other primary renal diseases. Conclusions Although final height remains suboptimal in children with ESRD, it has consistently improved over time.

AB - Background and objectives Growth and final height are of major concern in children with ESRD. This study sought to describe the distribution of adult height of patients who started renal replacement therapy (RRT) during childhood and to identify determinants of final height in a large cohort of RRT children. Design, setting, participants, & measurements A total of 1612 patients from 20 European countries who started RRT before 19 years of age and reached final height between 1990 and 2011 were included. Linear regression analyses were performed to calculate adjusted mean final height SD score (SDS) and to investigate its potential determinants. Results The median final height SDS was -1.65 (median of 168 cm in boys and 155 cm in girls). Fifty-five percent of patients attained an adult height within the normal range. Adjusted for age at start of RRT and primary renal diseases, final height increased significantly over time from -2.06 SDS in children who reached adulthood in 1990-1995 to -1.33 SDS among those reaching adulthood in 2006-2011. Older age at start of RRT, more recent period of start of RRT, cumulative percentage time on a functioning graft, and greater height SDS at initiation of RRT were independently associated with a higher final height SDS. Patients with congenital anomalies of the kidney and urinary tract and metabolic disorders had a lower final height than those with other primary renal diseases. Conclusions Although final height remains suboptimal in children with ESRD, it has consistently improved over time.

UR - http://www.scopus.com/inward/record.url?scp=84891837484&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891837484&partnerID=8YFLogxK

U2 - 10.2215/CJN.00890113

DO - 10.2215/CJN.00890113

M3 - Article

C2 - 24178977

AN - SCOPUS:84891837484

VL - 9

SP - 92

EP - 99

JO - Clinical journal of the American Society of Nephrology : CJASN

JF - Clinical journal of the American Society of Nephrology : CJASN

SN - 1555-9041

IS - 1

ER -